(P-101) A Phase 3 International, Multi-Center, Randomized, Open-Label, Assessor-Blind Study to Evaluate the Efficacy and Safety of Minocycline/EDTA/Ethanol (Mino-Lok) Therapy (MLT) vs Site-Specific Antimicrobial Lock in Combination with Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection

Monday, October 20, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Anne-Marie Chaftari, MD

Associate Professor
MD Anderson UT
Houston, Texas, United States

VR

Vinay Rathore, MD

All India Institute of Medical Sciences
Raipur, Chhattisgarh, India
RH

Ray Y. Hachem, MD,

Professor
MD Anderson UT
Houston, Texas, United States
TH

Toan T. Huynh, MD

Vice Chair, Professional Development & Academic Affairs
Surgical Critical Care and Acute Care Surgery, Atrium Health
Charlotte, North Carolina, United States
PC

Paul P. Cook, MD

Chief, Infectious Diseases
Brody School of Medicine at East Carolina University
Greenville, NC, United States
OC

Onix Cantres-Fonseca, MD

Advent Health Transplant Institute Orlando, Florida; VA Carribean Health-system, San Juan,PR
Orlando, Florida, United States
MR

Mayur Ramesh, MD

Senior Staff Physician, Infectious Diseases
Henry Ford Hospital
Detroit, MI, United States
Mark E. Rupp, MD (he/him/his)

Professor and Interim Chair, Department of Internal Medicine
University of Nebraska Medical Center
Omaha, NE, United States
LM

Leonard Mermel, DO

Warren Alpert Medical School of Brown University and Rhode Island Hospital
Providence, Rhode Island, United States
MC

Myron S. Czuczman, MD

CMO
Citius Pharmaceuticals
Cranford, New Jersey, United States
AL

Alan Lader, PhD

Citius Pharmaceuticals, Inc.
Cranford, New Jersey, United States
IR

Issam I. Raad, Distinguished Professor

Professor
MD Anderson UT
Houston, Texas, United States